Unaudited Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Net revenue	$ 17,993	$ 22,733	$ 63,026	$ 76,667
Cost of sales	6,300	9,990	20,346	28,599
Gross profit	11,693	12,743	42,680	48,068
Operating expenses:
Selling and marketing	6,549	12,804	20,547	33,466
General and administrative	5,442	7,177	17,837	22,517
Research and development	619	856	1,747	3,630
Amortization of intangible assets	1,303	1,198	3,909	3,593
Restructuring costs	244	0	244	0
Impairment expense	0	0	0	2,600
Gain from contingent consideration	0	(734)	0	(504)
Total operating expenses	14,157	21,301	44,284	65,302
Loss from operations	(2,464)	(8,558)	(1,604)	(17,234)
Other expense, net	(1,195)	(1,215)	(3,083)	(3,527)
Gain (loss) on derivative warrant liabilities	1,017	2,573	(5,467)	6,167
Loss before income tax	(2,642)	(7,200)	(10,154)	(14,594)
Income tax expense	(245)	0	(1,073)	0
Net loss	$ (2,887)	$ (7,200)	$ (11,227)	$ (14,594)
Basic and diluted weighted-average common shares outstanding (in shares)	5,533,555	3,726,779	5,511,089	3,099,130
Basic and diluted net loss per common share (in dollars per share)	$ (0.52)	$ (1.93)	$ (2.04)	$ (4.71)